2024-05-31 2025-05-31 false No description of principal activity Capium Accounts Production 1.1 15752430 2024-05-31 2025-05-31 15752430 bus:FullAccounts 2024-05-31 2025-05-31 15752430 bus:Micro-entities 2024-05-31 2025-05-31 15752430 bus:AuditExemptWithAccountantsReport 2024-05-31 2025-05-31 15752430 bus:SmallCompaniesRegimeForAccounts 2024-05-31 2025-05-31 15752430 bus:PrivateLimitedCompanyLtd 2024-05-31 2025-05-31 15752430 2024-05-31 2025-05-31 15752430 2025-05-31 15752430 bus:RegisteredOffice 2024-05-31 2025-05-31 15752430 core:WithinOneYear 2025-05-31 15752430 core:AfterOneYear 2025-05-31 15752430 1 2024-05-31 2025-05-31 15752430 bus:Director1 2024-05-31 2025-05-31 15752430 bus:Director1 2025-05-31 15752430 2023-05-31 15752430 bus:LeadAgentIfApplicable 2024-05-31 2025-05-31 15752430 2024-05-30 15752430 core:FurnitureFittings 2024-05-31 2025-05-31 15752430 core:FurnitureFittings 2025-05-31 15752430 core:FurnitureFittings 2024-05-30 15752430 core:ComputerEquipment 2024-05-31 2025-05-31 15752430 core:ComputerEquipment 2025-05-31 15752430 core:ComputerEquipment 2024-05-30 15752430 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-05-31 15752430 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-05-30 15752430 core:CostValuation core:Non-currentFinancialInstruments 2025-05-31 15752430 core:CostValuation core:Non-currentFinancialInstruments 2024-05-30 15752430 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-05-31 15752430 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-05-31 15752430 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-05-31 15752430 core:Non-currentFinancialInstruments 2025-05-31 15752430 core:Non-currentFinancialInstruments 2024-05-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15752430
England and Wales

 

 

 


Unaudited Financial Statements


for the year ended 31 May 2025

for

FUSION THERAPEUTICS LTD

Director Andrew Stephen LOCKHART
Registered Number 15752430
Registered Office 7 BOWFELL CLOSE
DAVENHAM NORTHWICH
CW9 8XE
Accountants Growth Accountants Ltd
Merlin House
Brunel Road
Theale
Berkshire
RG7 4AB
1
Director's report and financial statements
The director presents his/her/their report and accounts for the year ended 31 May 2025.
Director
The director who served the company throughout the year was as follows:
Andrew Stephen LOCKHART

On behalf of the board.


----------------------------------
Andrew Stephen LOCKHART
Director

Date approved: 21 July 2025
2
Report to the directors on the preparation of the unaudited statutory accounts of FUSION THERAPEUTICS LTD for the year ended 31 May 2025.
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of FUSION THERAPEUTICS LTD for the year ended 31 May 2025 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/.
This report is made solely to the Board of Directors of FUSION THERAPEUTICS LTD, as a body, in accordance with the terms of our engagement letter dated 21 July 2025. Our work has been undertaken solely to prepare for your approval the accounts of FUSION THERAPEUTICS LTD and state those matters that we have agreed to state to the Board of Directors of FUSION THERAPEUTICS LTD, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than FUSION THERAPEUTICS LTD and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that FUSION THERAPEUTICS LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of FUSION THERAPEUTICS LTD. You consider that FUSION THERAPEUTICS LTD is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of FUSION THERAPEUTICS LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
31 May 2025.



....................................................
Growth Accountants Ltd
Merlin House
Brunel Road
Theale
Berkshire
RG7 4AB
21 July 2025
3
  2025
    £ £
Fixed assets   8,415 
Current assets (50,860)  
Creditors: amount falling due within one year (2,980)  
Net current assets   (53,840)
Total assets less current liabilities   (45,425)
Net assets   (45,425)
 

     
Capital and reserves   (45,425)
 
NOTES TO THE ACCOUNTS

General Information
FUSION THERAPEUTICS LTD is a private company, limited by shares, registered in England and Wales, registration number 15752430, registration address 7 BOWFELL CLOSE, DAVENHAM NORTHWICH, CW9 8XE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
2.

Average number of employees

Average number of employees during the year was 1.

3.

Operating Lease Obligations

The company has a 3 year rental lease agreement with 2 years remaining on the lease. The value outstanding is £13,800 (including VAT).

For the year ended 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 21 July 2025 and were signed by:


--------------------------------
Andrew Stephen LOCKHART
Director
4